GHP Investment Advisors Inc. cut its position in CVS Health Co. (NYSE:CVS – Free Report) by 13.3% during the second quarter, HoldingsChannel.com reports. The fund owned 65,214 shares of the pharmacy operator’s stock after selling 10,005 shares during the period. GHP Investment Advisors Inc.’s holdings in CVS Health were worth $3,852,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Ables Iannone Moore & Associates Inc. acquired a new stake in shares of CVS Health in the fourth quarter worth approximately $32,000. First Community Trust NA boosted its stake in shares of CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after acquiring an additional 302 shares during the last quarter. Creekmur Asset Management LLC acquired a new position in CVS Health during the fourth quarter worth $34,000. Steph & Co. boosted its stake in CVS Health by 192.0% during the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 288 shares during the last quarter. Finally, ORG Partners LLC boosted its stake in CVS Health by 11,840.0% during the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 592 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.
CVS Health Price Performance
Shares of NYSE CVS opened at $57.98 on Friday. CVS Health Co. has a 1-year low of $52.77 and a 1-year high of $83.25. The company has a market cap of $72.94 billion, a price-to-earnings ratio of 10.19, a price-to-earnings-growth ratio of 0.79 and a beta of 0.53. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. The stock’s 50-day moving average is $58.28 and its two-hundred day moving average is $63.17.
CVS Health Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, August 1st. Investors of record on Monday, July 22nd were given a $0.665 dividend. The ex-dividend date of this dividend was Monday, July 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.59%. CVS Health’s dividend payout ratio (DPR) is presently 46.75%.
Analysts Set New Price Targets
A number of equities analysts have weighed in on CVS shares. Wells Fargo & Company boosted their price objective on CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research note on Monday, August 12th. Baird R W raised CVS Health to a “hold” rating in a research note on Thursday, May 30th. Evercore ISI lowered their price objective on CVS Health from $65.00 to $62.00 and set an “outperform” rating on the stock in a research note on Thursday, August 8th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $68.00 price target on shares of CVS Health in a research note on Wednesday, September 4th. Finally, Barclays decreased their price target on CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a research note on Thursday, August 8th. Eleven investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $72.10.
View Our Latest Analysis on CVS Health
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Stories
- Five stocks we like better than CVS Health
- What is Put Option Volume?
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- 3 Warren Buffett Stocks to Buy Now
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.